BIOAVAILABILITY OF DIGOXIN CAPSULES AND TABLETS - EFFECT OF COADMINISTERED FLUID VOLUME

被引:12
|
作者
BUSTRACK, JA
KATZ, JD
HULL, JH
FOSTER, JR
HAMMOND, JE
CHRISTENSON, RH
机构
[1] BURROUGHS WELLCOME CO, DEPT CLIN RES, RES TRIANGLE PK, NC 27709 USA
[2] UNIV N CAROLINA, SCH PHARM, DIV PHARM PRACTICE, CHAPEL HILL, NC 27514 USA
[3] UNIV N CAROLINA, SCH MED, DEPT PATHOL, CHAPEL HILL, NC 27514 USA
[4] UNIV N CAROLINA, SCH MED, DEPT MED, CHAPEL HILL, NC 27514 USA
[5] UNIV N CAROLINA, SCH MED, DEPT BIOCHEM, CHAPEL HILL, NC 27514 USA
[6] UNIV N CAROLINA, DEPT MED, CHAPEL HILL, NC 27514 USA
[7] UNIV N CAROLINA, DEPT HOSP LABS, CHAPEL HILL, NC 27514 USA
关键词
D O I
10.1002/jps.2600731018
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
引用
收藏
页码:1397 / 1400
页数:4
相关论文
共 50 条
  • [41] EFFECT OF SULFASALAZINE ON DIGOXIN BIOAVAILABILITY
    JUHL, RP
    SUMMERS, RW
    GUILLORY, JK
    BLAUG, SM
    CHENG, FH
    BROWN, DD
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1976, 20 (04) : 387 - 394
  • [42] ABSORPTION OF DIGOXIN FROM TABLETS AND CAPSULES IN SUBJECTS WITH MALABSORPTION-SYNDROMES
    HEIZER, WD
    PITTMAN, AW
    HAMMOND, JE
    FITCH, DD
    BUSTRACK, JA
    HULL, JH
    DICP-THE ANNALS OF PHARMACOTHERAPY, 1989, 23 (10): : 764 - 769
  • [43] EFFECT OF QUINIDINE ON DIGOXIN BIOAVAILABILITY
    HAGER, WD
    MAYERSOHN, M
    GRAVES, P
    CLINICAL RESEARCH, 1981, 29 (01): : A22 - A22
  • [44] EFFECT OF QUINIDINE ON DIGOXIN BIOAVAILABILITY
    PEDERSEN, KE
    CHRISTIANSEN, BD
    KLITGAARD, NA
    NIELSENKUDSK, F
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 24 (01) : 41 - 47
  • [45] EFFECT OF VOLUME OF IMMERSION FLUID ON DISINTEGRATION TIME OF TABLETS
    KITAZAWA, S
    JOHNO, I
    MINOUCHI, T
    OBATA, H
    OKADA, J
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 1977, 97 (06): : 654 - 660
  • [46] EFFECT OF MAGNESIUM-ALUMINUM HYDROXIDE AND KAOLIN-PECTIN ON ABSORPTION OF DIGOXIN FROM TABLETS AND CAPSULES
    ALLEN, MD
    GREENBLATT, DJ
    HARMATZ, JS
    SMITH, TW
    JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 21 (01): : 26 - 30
  • [47] MULTICENTER CLINICAL-STUDY ON THERAPY WITH DIGOXIN TABLETS WITH HIGH BIOAVAILABILITY
    FLASCH, CI
    HEINZ, N
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1979, 29-2 (11): : 1737 - 1742
  • [48] EQUIVALENT BIOAVAILABILITY FROM DIGOXIN ELIXIR AND RAPID-DISSOLUTION TABLETS
    GREENBLATT, DJ
    DUHME, DW
    KOCHWESE.J
    SMITH, TW
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1974, 229 (13): : 1774 - 1776
  • [49] VARIABILITY OF STEADY-STATE DIGOXIN KINETICS DURING ADMINISTRATION OF TABLETS OR CAPSULES
    JOHNSON, BF
    LINDENBAUM, J
    BUDNITZ, E
    MARWAHA, R
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1986, 39 (03) : 306 - 312
  • [50] RELATIVE AND ABSOLUTE BIOAVAILABILITY OF CIBENZOLINE CAPSULES AND TABLETS IN HEALTHY-SUBJECTS
    MASSARELLA, J
    SILVESTRI, T
    LIN, A
    JOURNAL OF PHARMACEUTICAL SCIENCES, 1986, 75 (09) : 894 - 896